News | November 01, 2011

Cardiovascular Research Foundation, Harvard Angiographic Core Lab Collaborate for Research

November 1, 2011 – The Angiographic and Imaging Core Laboratories of the Clinical Trials Center (CTC) at the Cardiovascular Research Foundation (CRF) in New York have formed a collaborative alliance with the Angiographic Core Laboratory of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HFMP). Led by distinguished physicians Gregg W. Stone, Jeffrey J. Popma and Gary S. Mintz, the collaborative research alliance will be known as CRFiCOR.

CRFiCOR is now united in contracting and performing research projects at its New York City and Boston campuses to provide expert clinical research support and comprehensive imaging Core Lab services for trial sponsors, investigators and hospitals. The new CRFiCOR alliance, as part of the CRF Clinical Trials Center, will specialize in all aspects of core laboratory analysis, including coronary angiography, carotid and peripheral angiography, intravascular imaging and structural heart disease assessment (including valve interventions), as well as electrocardiography, computed tomography (CT) and magnetic resonance (MR) imaging.

CRF’s Angiographic and Imaging Core Laboratories are one of the world’s leading centers for independent investigation, having performed highly complex analyses for hundreds of trials over the last two decades. HMFP’s Angiographic Core Laboratory has performed independent angiographic analyses and interpretations for 14 years in Boston. Collectively, CRFiCOR has performed imaging studies in more than 100,000 patients.

For more information: www.crf.org

 


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now